KRAS and colorectal carcinoma: Thus, oncolytic virotherapy appears to be a promising antitumor strategy for inducing autophagy-related death in KRAS/BRAF wild-type and KRAS-mutant CRC cells by suppressing the EGFR-KRAS signaling pathway.